Year |
Citation |
Score |
2013 |
Knight A, Arnouk H, Britt W, Gillespie GY, Cloud GA, Harkins L, Su Y, Lowdell MW, Lamb LS. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells. Plos One. 8: e68729. PMID 23950874 DOI: 10.1371/Journal.Pone.0068729 |
0.338 |
|
2011 |
Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, Langford CP, Arnouk H, Su Y, Haines HL, Suarez-Cuervo C, Lamb LS. Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme. Journal of Neuro-Oncology. 101: 179-88. PMID 20532954 DOI: 10.1007/S11060-010-0245-2 |
0.374 |
|
2010 |
Arnouk H, Zynda ER, Wang XY, Hylander BL, Manjili MH, Repasky EA, Subjeck JR, Latif Kazim A. Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 26: 366-75. PMID 20210603 DOI: 10.3109/02656730903485910 |
0.344 |
|
2007 |
Sharma S, Tammela J, Wang X, Arnouk H, Driscoll D, Mhawech-Fauceglia P, Lele S, Kazim AL, Odunsi K. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5889-96. PMID 17908984 DOI: 10.1158/1078-0432.Ccr-07-0703 |
0.527 |
|
2006 |
Manjili MH, Arnouk H, Knutson KL, Kmieciak M, Disis ML, Subjeck JR, Kazim AL. Erratum to: Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast Cancer Research and Treatment. 96: 243. PMID 28303485 DOI: 10.1007/S10549-006-9163-6 |
0.581 |
|
2006 |
Wang XY, Arnouk H, Chen X, Kazim L, Repasky EA, Subjeck JR. Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma. Journal of Immunology (Baltimore, Md. : 1950). 177: 1543-51. PMID 16849461 DOI: 10.4049/Jimmunol.177.3.1543 |
0.482 |
|
2006 |
Kulawiec M, Arnouk H, Desouki MM, Kazim L, Still I, Singh KK. Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer. Cancer Biology & Therapy. 5: 967-75. PMID 16775426 DOI: 10.4161/Cbt.5.8.2880 |
0.379 |
|
2006 |
Manjili MH, Arnouk H, Knutson KL, Kmieciak M, Disis ML, Subjeck JR, Kazim AL. Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast Cancer Research and Treatment. 96: 233-41. PMID 16211331 DOI: 10.1007/S10549-005-9044-4 |
0.598 |
|
2006 |
Facciponte JG, Wang XY, MacDonald IJ, Park JE, Arnouk H, Grimm MJ, Li Y, Kim H, Manjili MH, Easton DP, Subjeck JR. Heat shock proteins HSP70 and GP96: structural insights. Cancer Immunology, Immunotherapy : Cii. 55: 339-46. PMID 16032399 DOI: 10.1007/S00262-005-0020-Y |
0.434 |
|
2006 |
Kulawiec M, Arnouk H, Desouki M, Kazim L, Still I, Singh K. Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer cells Mitochondrion. 6: 16-17. DOI: 10.1016/J.Mito.2006.08.039 |
0.342 |
|
Show low-probability matches. |